Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)
The summary for the Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed): The purpose of this notice of funding opportunity (NOFO) is to invite applications for the Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) programs to provide administrative and shared research support to enhance HIV/AIDS research. CFARs provide infrastructure, expertise, resources, and services not readily obtained through other funding mechanisms. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.
| Federal Grant Title: | Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PAR-28-090 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.121, 93.233, 93.242, 93.279, 93.307, 93.310, 93.361, 93.393, 93.394, 93.395, 93.396, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855, 93.865, 93.866, 93.989 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | May 25th, 2029 |
| Original Application Deadline: | May 25th, 2029 |
| Posted Date: | October 16th, 2026 |
| Creation Date: | October 16th, 2026 |
| Archive Date: | July 25th, 2029 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 6 |
| Cost Sharing or Matching: | No |
| Last Updated: | October 16th, 2026 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
- Grant Announcement Contact
- CFAR Program
[email protected]
[email protected] - Similar Government Grants
- • NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, an...
- • Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)
- • Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028...
- • Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Tr...
- • HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
- • Epidemiological and Behavioral Research in Oral Health
- • Metagenomic Analyses of the Oral Microbiome
- • Phase Iii Clinical Trials in Oral Infectious Diseases
- More Grants from the National Institutes of Health
- • NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, an...
- • Specialized Alcohol Research Centers (P50 Clinical trial Optional)
- • Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Bio...
- • Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) ...
- • Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Min...
